Covered recipient · General Payments record
PAUL AARON ROSS IKEMIRE
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2018–2021
$874.74
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $274.32 | 10 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $151.44 | 3 |
| GlaxoSmithKline, LLC. | $49.97 | 3 |
| ABBVIE INC. | $40.93 | 2 |
| E.R. Squibb & Sons, L.L.C. | $17.69 | 1 |
| PFIZER INC. | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $18.11 | 01/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794909667 | CMS |
| AbbVie Inc. | $22.82 | 06/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794909673 | CMS |
| AstraZeneca Pharmaceuticals LP | $6.03 | 11/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 830096707 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.01 | 11/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 829885365 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.40 | 11/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 829578713 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.69 | 11/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 783497893 | CMS |
| GlaxoSmithKline, LLC. | $14.78 | 02/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 802525721 | CMS |
| GlaxoSmithKline, LLC. | $19.62 | 04/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801622349 | CMS |
| GlaxoSmithKline, LLC. | $15.57 | 11/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801618785 | CMS |
| PFIZER INC. | $14.29 | 10/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833528125 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.